370 related articles for article (PubMed ID: 25170198)
21. Management of recurrent hepatitis C after liver transplantation.
Teixeira R; Papatheodoridis GV; Burroughs AK
J Viral Hepat; 2001 May; 8(3):159-68. PubMed ID: 11380792
[TBL] [Abstract][Full Text] [Related]
22. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
[TBL] [Abstract][Full Text] [Related]
23. Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
Tanimine N; Tanaka Y; Abe T; Piao J; Chayama K; Ohdan H
Transplantation; 2016 Feb; 100(2):355-64. PubMed ID: 26714120
[TBL] [Abstract][Full Text] [Related]
24. Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation.
Joshi D; Salehi S; Brereton H; Arno M; Quaglia A; Heaton N; O'Grady J; Agarwal K; Aluvihare V
Liver Transpl; 2013 Apr; 19(4):383-94. PubMed ID: 23408392
[TBL] [Abstract][Full Text] [Related]
25. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation.
García-Reyne A; Lumbreras C; Fernández I; Colina F; Abradelo M; Magan P; San-Juan R; Manrique A; López-Medrano F; Fuertes A; Lizasoain M; Moreno E; Aguado JM
Transpl Infect Dis; 2013 Aug; 15(4):405-15. PubMed ID: 23725370
[TBL] [Abstract][Full Text] [Related]
26. Management of hepatitis C infection before and after liver transplantation.
Fagiuoli S; Ravasio R; Lucà MG; Baldan A; Pecere S; Vitale A; Pasulo L
World J Gastroenterol; 2015 Apr; 21(15):4447-56. PubMed ID: 25914454
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C in the liver transplant recipient: current understanding and treatment.
Rosen HR
Microbes Infect; 2002 Oct; 4(12):1253-8. PubMed ID: 12467767
[TBL] [Abstract][Full Text] [Related]
28. Virology and pathogenesis of hepatitis C virus recurrence.
Ramírez S; Pérez-Del-Pulgar S; Forns X
Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
[TBL] [Abstract][Full Text] [Related]
29. Current management and perspectives for HCV recurrence after liver transplantation.
Coilly A; Roche B; Samuel D
Liver Int; 2013 Feb; 33 Suppl 1():56-62. PubMed ID: 23286847
[TBL] [Abstract][Full Text] [Related]
30. [The recurrence of hepatitis C virus after liver transplantation].
Nemes B; Sárváry E; Gerlei Z; Fazakas J; Doros A; Németh A; Görög D; Fehérvári I; Máthé Z; Gálffy Z; Pár A; Schuller J; Telegdy L; Fehér J; Lotz G; Schaff Z; Nagy P; Járay J; Lengyel G
Orv Hetil; 2007 Oct; 148(42):1971-9. PubMed ID: 17932003
[TBL] [Abstract][Full Text] [Related]
31. Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.
Yoshida EM; Kwo P; Agarwal K; Duvoux C; Durand F; Peck-Radosavljevic M; Lilly L; Willems B; Vargas H; Kumar P; Brown RS; Horsmans Y; De-Oertel S; Arterburn S; Dvory-Sobol H; Brainard DM; McHutchison JG; Terrault N; Rizzetto M; Müllhaupt B
Ann Hepatol; 2017; 16(3):375-381. PubMed ID: 28425407
[TBL] [Abstract][Full Text] [Related]
32. Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.
Ueda Y; Uemoto S
Transplantation; 2016 Jan; 100(1):54-60. PubMed ID: 26335914
[TBL] [Abstract][Full Text] [Related]
33. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
34. Management of recurrent hepatitis C virus after liver transplantation.
Jiménez-Pérez M; González-Grande R; Rando-Muñoz FJ
World J Gastroenterol; 2014 Nov; 20(44):16409-17. PubMed ID: 25469009
[TBL] [Abstract][Full Text] [Related]
35. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
[TBL] [Abstract][Full Text] [Related]
36. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Charlton M; Seaberg E
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
[TBL] [Abstract][Full Text] [Related]
37. Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants.
Lim EJ; Chin R; Angus PW; Torresi J
World J Gastroenterol; 2012 May; 18(18):2172-9. PubMed ID: 22611309
[TBL] [Abstract][Full Text] [Related]
38. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M
Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
[TBL] [Abstract][Full Text] [Related]
40. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]